Treffer: Developing a pharmacist preceptorship programme to support UK advanced level practice: a consensus study.

Title:
Developing a pharmacist preceptorship programme to support UK advanced level practice: a consensus study.
Authors:
McLean MA; Pharmacy Services NHS Greater Glasgow and Clyde, NHS Greater Glasgow and Clyde, Clarkston Court, 56 Busby Road, Clarkston, Glasgow, G76 7AT, Scotland, UK. mairi-anne.mclean@ggc.scot.nhs.uk.; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral St, Glasgow, G4 0RE, Scotland, UK. mairi-anne.mclean@ggc.scot.nhs.uk., Forsyth P; Golden Jubilee University National Hospital, Agamemnon Street, Clydebank, G81 4DY, UK., Dunlop E; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral St, Glasgow, G4 0RE, Scotland, UK., Boyter AC; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral St, Glasgow, G4 0RE, Scotland, UK.
Source:
International journal of clinical pharmacy [Int J Clin Pharm] 2025 Oct; Vol. 47 (5), pp. 1248-1260. Date of Electronic Publication: 2025 Apr 16.
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE
Imprint Name(s):
Original Publication: Dordrecht : Springer
References:
Palliat Med. 2017 Sep;31(8):684-706. (PMID: 28190381)
Curr Pharm Teach Learn. 2021 Mar;13(3):198-202. (PMID: 33641727)
Int J Pharm Pract. 2019 Dec;27(6):479-489. (PMID: 31287208)
Res Social Adm Pharm. 2023 Jan;19(1):110-122. (PMID: 36100521)
J Clin Epidemiol. 2019 Apr;108:110-120. (PMID: 30557677)
Nurse Educ Pract. 2016 Nov;21:29-36. (PMID: 27710811)
Nurse Res. 2006;14(1):59-70. (PMID: 17100214)
Int J Pharm Pract. 2022 Dec 31;30(6):559-566. (PMID: 36047534)
J Adv Nurs. 2000 Oct;32(4):1008-15. (PMID: 11095242)
Int J Pharm Pract. 2021 Aug 11;29(4):299-307. (PMID: 33978740)
BMC Health Serv Res. 2016 Nov 8;16(1):637. (PMID: 27825345)
Int J Clin Pharm. 2016 Jun;38(3):655-62. (PMID: 26846316)
Int J Clin Pharm. 2021 Oct;43(5):1426-1430. (PMID: 33991288)
Am J Pharm Educ. 2019 Nov;83(9):7520. (PMID: 31871362)
Can Pharm J (Ott). 2018 Aug 17;151(5):315-321. (PMID: 31080531)
Fam Pract. 1993 Mar;10(1):76-81. (PMID: 8477899)
Am J Pharm Educ. 2020 Oct;84(10):ajpe8039. (PMID: 33149332)
Can J Hosp Pharm. 2020 May-Jun;73(3):177-185. (PMID: 32616943)
Int J Clin Pharm. 2022 Aug;44(4):1013-1027. (PMID: 35799036)
PLoS One. 2018 Apr 30;13(4):e0196471. (PMID: 29709006)
Contributed Indexing:
Keywords: Advanced practice; Consensus; Pharmacy; Preceptorship
Entry Date(s):
Date Created: 20250416 Date Completed: 20250916 Latest Revision: 20250916
Update Code:
20250916
PubMed Central ID:
PMC12432034
DOI:
10.1007/s11096-025-01909-z
PMID:
40238030
Database:
MEDLINE

Weitere Informationen

Background: Globally, health professionals are advancing roles to meet growing healthcare demands. Pharmacists are increasingly required to deliver autonomous, holistic, highly complex advanced care. Preceptorship could be used more widely to support delivery of advanced pharmaceutical care.
Aim: The aim of this study was to formulate statements describing features of preceptorship programmes, and to measure consensus in the Scottish pharmacy workforce on the applicability of these statements to an advanced pharmacist preceptorship programme.
Method: Phase 1-formulation of statements relating to key features of healthcare preceptorship programmes through literature review and author expertise. Phase 2-modified nominal group technique (m-NGT) to add expert ideas to phase 1 statements and to reach consensus on statement wording. Phase 3-a two round modified Delphi (m-Delphi) survey to measure consensus in the Scottish pharmacy workforce on whether the features presented should be part of a Scottish advanced pharmacist preceptorship programme. Consensus agreement was set at 75% for m-NGT and m-Delphi.
Results: Fifty-one statements were generated from literature. Seven statements were generated by authors. Three statements were generated by experts during m-NGT stage: 61 statements progressed to m-Delphi. After two rounds (n = 194 and 144 participants in round one and two respectively) of m-Delphi, consensus was reached on 48 of the 61 statements across categories including programme design, preceptor training requirements and programme assessment.
Conclusion: This study provides a strong basis for research into the impact of preceptorship programmes for pharmacists working towards the advanced career stage.
(© 2025. The Author(s).)

Conflicts of interest: The authors declared that they have no conflicts of interest.